6.27
-0.13
(-2.03%)
At close: April 10 at 4:00:01 PM EDT
6.58
+0.31
+(4.94%)
After hours: April 10 at 5:55:05 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
Total Assets
268,535
84,180
45,095
Total Liabilities Net Minority Interest
11,093
156,648
87,700
Total Equity Gross Minority Interest
257,442
-72,468
-42,605
Total Capitalization
257,442
-72,468
-42,605
Common Stock Equity
257,442
-72,468
-42,605
Capital Lease Obligations
171
324
461
Net Tangible Assets
257,442
-72,468
-42,605
Working Capital
256,235
79,539
40,780
Invested Capital
257,442
-72,468
-42,605
Tangible Book Value
257,442
-72,468
-42,605
Total Debt
171
324
461
Share Issued
33,376.06
31,853.70
31,853.70
Ordinary Shares Number
33,376.06
31,853.70
31,853.70
12/31/2022 - 9/13/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BCAX Bicara Therapeutics Inc.
10.15
-2.40%
DSGN Design Therapeutics, Inc.
2.7900
-5.90%
UPB Upstream Bio, Inc.
6.40
-1.99%
SEPN Septerna, Inc.
5.16
-8.02%
MAZE Maze Therapeutics, Inc.
7.60
-4.64%
CTNM Contineum Therapeutics, Inc.
4.1300
-10.61%
DNTH Dianthus Therapeutics, Inc.
15.60
-4.47%
AARD Aardvark Therapeutics, Inc. Common Stock
7.02
-9.88%
BOLD Boundless Bio, Inc.
1.1900
-0.83%
MLYS Mineralys Therapeutics, Inc.
12.19
-4.99%